Weight-loss drugs like Wegovy may help stave off some cancers
Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity.
obesity
Decades-old law limits access to Wegovy for Medicaid beneficiaries
New medications like Wegovy are changing the way people lose weight and manage obesity, but many Medicaid beneficiaries can't get them.
Medicare plans can now cover Wegovy for patients at risk of heart disease
This change follows the recent FDA approval of the weight-loss drug for preventing heart attack and stroke in people with overweight or obesity.
In 'Unshrinking,' a writer discusses coming out as fat and pushing back against bias
Kate Manne tried to shrink her body for years before embracing her size as part of a "natural, normal human variation." She says the fight against fat phobia must start in the doctor's office.
How high blood sugar, hypertension and obesity can add up to cancer risk
It's known that obesity is linked to many cancers. A study shows metabolic syndrome, which includes factors like high blood pressure and insulin resistance, also drives increased risk.
Opinion: Women with obesity are often restricted from IVF. That's discriminatory
Despite the lack of medical evidence for doing so, fertility clinics bar women over a certain BMI from their services. One writer makes the case such limits are unfair and unscientific.
FDA approves Zepbound, a new obesity drug that will take on Wegovy
Eli Lilly said the obesity medicine, which helped adults in clinical studies lose about 20% of their body weight, will be available in the U.S. by the end of the year. The list price will be $1,060.
What the U.S. could learn from Japan about making healthy living easier
On a trip back to her parents' native country, a writer rediscovers what makes it different. The urban design, and a culture that values longevity, make good health come al lot more naturally.
Study finds pandemic pressures put SNAP recipients at risk for eating disorders
Nearly half of the people on the federal Supplemental Nutrition Assistance Program — also known as SNAP — experienced food insecurity during the pandemic. That’s up from a quarter of recipients prior to the COVID-19 outbreak.
Eli Lilly releases more data for new obesity drug, moving toward fast-track approval
There's already a huge demand for existing weight-loss drugs, so the new medication is highly anticipated. Obesity affects an estimated 650 million adults globally.